Clinical trial
Efficacy of Selegiline in Negative Symptoms of Schizophrenia
NCT00456976 · Tabriz University, Other · Completed
Key facts
| NCT number | NCT00456976 |
|---|---|
| Title | Efficacy of Selegiline in Negative Symptoms of Schizophrenia |
| Official title | Efficacy of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Inpatients With Chronic Schizophrenia |
| Lead sponsor | Tabriz University, Other |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Selegiline |
| Enrollment | 70 |
| Start date | Apr 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 5, 2007 |
| Last update posted | Jul 23, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: